Hepregen Awarded $500,000 Massachusetts Life Sciences Center Grant
Hepregen, a leading provider of bioengineered solutions that increase success in drug development, was awarded a $500,000 grant as part of the Small Business Matching Grants program
Blog
Phytoceuticals Heals Wounds Through An Easy To Use Spray
This is a new solution that is poised to become the standard of care in wound management because of effective speed, ease of use and cost savings.
InSite Vision Is Developing Treatment For Common Eye Disease Blepharitis, For Which There Is Currently No Approved Treatment
InSite Vision has reached an agreement with the FDA on a Special Protocol Assessment for the design of a Phase 3 clinical trial of treatment in patients with blepharitis.
Ampio Pharmaceuticals Shows Promising Results In Treating The Most Common Male Sexual Dysfunction
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction.
Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide
In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.
BMEYE’s Heart Monitoring Technology May Set A New Standard In Patient Care
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood.
Cynvenio Biosystems Selected as 2011 FiReStarter Company
Strategic News Service recently announced that Cynvenio Biosystems has been selected as a 2011 FiReStarter company, to be featured at its annual Future in Review technology conference.
Newly Launched NICE Quality Standards For CKD Form Framework For Health Care Professionals
Kidney disease is more common than people might think. The bean shaped organs responsible for a host of functions cause havoc when things go awry.
Protected: Functional Neuromodulation CEO: Deep Brain Stimulation the Next Step in Alzheimer’s Disease
There is no excerpt because this is a protected post.
Adherex Enrolls First Patient in Clinical Trial For Metastatic Breast Cancer
In 2010, NCI estimated that 207,090 women were diagnosed with breast cancer, while 39,840 women likely died from the disease.